Skip to content

Clinical trials

Neurocognitive Disorders trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurocognitive Disorders Country / region: Switzerland Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20131
20161
20171
20212
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Terminated3
Active, not recruiting1
Not yet recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital, Basel, Switzerland3
Centre Hospitalier Universitaire Vaudois2
Eling DeBruin2
Luzerner Kantonsspital1
University Hospital, Geneva1
University of Zurich1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurocognitive Disorders10
Cognition Disorders3
Cognitive Dysfunction3
Alzheimer Disease2
Mental Disorders2
Nervous System Diseases2
Acquired Immunodeficiency Syndrome1
Cerebrovascular Disorders1
Communicable Diseases1
Dementia1

Trials

Showing 76 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.